Back to results
US 9,006,241 B2Granted
Pyrimidine derivatives
AssigneeNoviga Research AB
InventorsMarita Högberg, Emma Dahlstedt, Olof Smitt, Tommy Johansson
Life of this patent
Estimating the term…
Abstract
The invention provides novel pyrimidine derivatives of formula (I), methods of preparing such compounds, pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer; wherein R1-R11, Z, and Y are as defined in the specification.
Claims45
A compound of formula I or a pharmaceutically acceptable ester, solvate or salt thereof,
- wherein
- Z represents carbon or nitrogen;
- Y represents carbon or nitrogen, wherein one of Z and Y represents nitrogen;
- R1, R3, and R8 are independently selected from the group consisting of hydrogen and (C1-C4)alkyl;
- R2 is selected from the group consisting of hydrogen, (C1-C4)alkyl, (C1-C4)alkyl-NH(C1-C4)alkyl, (C1-C4)alkyl-N[(C1-C4)alkyl ]2, and (CO)OH;
- R4, R5, R6, and R7 are independently selected from the group consisting of hydrogen, halogen, hydroxy, amino, nitro, cyano, (C1-C4)alkyl, (C1-C4)alkyl-OH, (C1-C4)alkyl-NH2, (C1-C4)alkyl-NH(C1-C4)alkyl, (C1-C4)alkyl-N[(C1-C4)alkyl]2, (C1-C4)alkyl-NH(CO)(C1-C4)alkyl, (CO)OH, (CO)NH2, (CO)NH(C1-C4)alkyl, (CO)N[(C1-C4)alkyl]2, O(C1-C4)alkyl, O(C1-C4)alkyl(C2-C5)heterocyclyl, O(C1-C4)alkyl(C2-C5)heterocyclyl(C1-C4)alkyl, O(C1-C4)alkyl(CO)OH, O(C1-C4)alkyl(CO)NH(C1-C4)alkyl, O(C1-C4)alkyl(CO)N[(C1-C4)alkyl]2, OCF3, NH(C1-C4)alkyl, N[(C1-C4)alkyl ]2, NH(CO)(C1-C4)alkyl, NHSO2(C1-C4)alkyl, N[(C1-C4)alkyl]SO2(C1-C4)alkyl, SH, S(C1-C4)alkyl, SO2NH2, SO2NH(C1-C4)alkyl, and SO2N[(C1-C4)alkyl]2;
- each R10 is independently selected from the group consisting of hydrogen, amino, and (C1-C4)alkyl when Z or Y is carbon;
- R11 is selected from the group consisting of hydrogen, amino, (C1-C4)alkyl, (C1-C4)alkyl(C2-C5)heterocyclyl, (C1-C4)alkyl(C2-C5)heterocyclyl(C1-C4)alkyl, (CO)OH, (CO)NH2, (CO)NH(C1-C4)alkyl, (CO)N[(C1-C4)alkyl]2, (CO)(C1-C4)alkyl, (C2-C5)heterocyclyl, (C2-C5)heterocyclyl(C1-C4)alkyl, NH(C1-C4)alkyl, N[(C1-C4)alkyl]2, NH(CO)(C1-C4)alkyl, NHSO2(C1-C4)alkyl, N[(C1-C4)alkyl]SO2(C1-C4)alkyl, SO2NH2, SO2NH(C1-C4)alkyl, and SO2N[(C1-C4)alkyl]2;
- R9 represents
- R12, R13, and R14 are independently selected from the group consisting of hydrogen, halogen, hydroxy, (C1-C4)alkyl, O(C1-C4)alkyl, NH(C1-C4)alkyl, and N[(C1-C4)alkyl]2;
- R15 is selected from hydrogen and (C1-C4)alkyl;
- and
- R16 and R17 are independently selected from the group consisting of hydrogen, halogen, (C1-C4)alkyl, (C1-C4)alkyl(C2-C5)heterocyclyl, (C1-C4)alkyl(C2-C5)heterocyclyl(C1-C4)alkyl, (C1-C4)alkyl(CO)OH, (C1-C4)alkyl(CO)NH2, (C1-C4)alkyl(CO)NH(C1-C4)alkyl, (C1-C4)alkyl(CO)N[(C1-C4)alkyl]2, (C1-C4)alkyl-OH, (C1-C4)alkyl-O(C1-C4)alkyl, (C1-C4)alkyl-NH(C1-C4)alkyl, (C1-C4)alkyl-N[(C1-C4)alkyl]2, (C1-C4)alkyl-NH(CO)(C1-C4)alkyl, (CO)OH, (CO)NH2, (CO)NH(C1-C4)alkyl, (CO)N[(C1-C4)alkyl]2, (CO)(C1-C4)alkyl, (CO)(C2-C5)heterocyclyl, and (CO)(C2-C5)heterocyclyl)(C1-C4)alkyl.
10 more elements
Dependencies are inferred from the claim text.